Liu Shiqi, Wang Wei, Yang Yang, Huang Zhuo
State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
IDG/McGovern Institute for Brain Research, Peking University, Beijing, China.
Med Rev (2021). 2025 Mar 3;5(3):231-243. doi: 10.1515/mr-2024-0085. eCollection 2025 Jun.
Cardiac ion channels are critical transmembrane proteins that mediate almost all aspects of cardiac function including generation and propagation of cardiac action potential (AP) as well as maintenance of normal heart excitability and contraction. In addition, the pivotal role of cardiac ion channels in cardiac health and disease is underscored by the profound effects of their dysfunctional mutations on various arrhythmias. Hence, ion channels are vital targets for antiarrhythmic drugs. In this review, we first summarize the characteristics, structure of the various cardiac ion channels and their specific roles in cardiac electrophysiology. Subsequently, we highlight the implications of genetic mutations that disrupt ion channel function, which are associated with inherited cardiac arrhythmias. Finally, we address antiarrhythmic drugs acting on cardiac ion channels respectively, according to their therapeutic targets. In conclusion, this manuscript aims to review the physiology, pathophysiology and pharmacology of the most prominent ventricular Na, Ca, K, and K ion channels.
心脏离子通道是关键的跨膜蛋白,介导心脏功能的几乎所有方面,包括心脏动作电位(AP)的产生和传播,以及维持正常的心脏兴奋性和收缩。此外,心脏离子通道功能失调性突变对各种心律失常具有深远影响,这突出了其在心脏健康和疾病中的关键作用。因此,离子通道是抗心律失常药物的重要靶点。在本综述中,我们首先总结各种心脏离子通道的特征、结构及其在心脏电生理学中的特定作用。随后,我们强调破坏离子通道功能的基因突变的影响,这些突变与遗传性心律失常有关。最后,我们根据其治疗靶点分别阐述作用于心脏离子通道的抗心律失常药物。总之,本文旨在综述最主要的心室钠、钙、钾和氯通道的生理学、病理生理学和药理学。